Omega Therapeutics (OMGA) SEC Filings & 10K Form

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free OMGA Stock Alerts

$2.42

-0.14 (-5.47%)

(As of 04/18/2024 ET)

Compare

Recent Omega Therapeutics SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
04/16/2024 3:20 PM	Omega Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/12/2024 11:03 AM	Omega Therapeutics (Subject)	Form SC 13G/A
02/09/2024 3:17 PM	HarbourVest Partners L.P. (Filed by) Omega Therapeutics (Subject)	Form SC 13G/A
02/09/2024 8:28 AM	FMR LLC (Filed by) Omega Therapeutics (Subject)	Form SC 13G/A
11/09/2023 6:03 AM	Omega Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/09/2023 6:03 AM	Omega Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
09/26/2023 4:29 PM	Omega Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
09/22/2023 4:10 PM	Omega Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/29/2023 3:30 PM	Omega Therapeutics (Issuer) Werner Michelle C (Reporting)	Form 3 Initial statement of beneficial ownership of securities
08/29/2023 3:32 PM	Omega Therapeutics (Issuer) Werner Michelle C (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
08/29/2023 6:03 AM	Omega Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/13/2023 3:00 PM	Omega Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/12/2023 3:21 PM	Omega Therapeutics (Issuer) SCHADE CHRISTIAN S (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/12/2023 3:01 PM	Omega Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/12/2023 3:15 PM	Omega Therapeutics (Issuer) SCHADE CHRISTIAN S (Reporting)	Form 3 Initial statement of beneficial ownership of securities
05/04/2023 6:09 AM	Omega Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
05/04/2023 6:09 AM	Omega Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/01/2023 2:03 PM	Omega Therapeutics (Subject) Young Richard A (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
04/25/2023 7:00 AM	Omega Therapeutics (Filer)	Form DEF 14A
04/25/2023 7:03 AM	Omega Therapeutics (Filer)	Form DEFA14A

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies:

SEC Filings Tools:

This page (NASDAQ:OMGA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Omega Therapeutics (OMGA) SEC Filings & 10K Form

Recent Omega Therapeutics SEC Filings

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info